Logo Loading...

Phone: +91 7499180452

Gene Therapy Market by Size, Share, Types (Somatic Gene Therapy, Germline Therapy), Applications (Oncology, Rare Diseases, Infectious Disease) and Forecasts by 2027

Global Gene Therapy market was valued at around USD 2.26 billion in 2020 and is expected to grow with the CAGR of 33.5% during forecast period 2021-2027.

Nowadays a business needs to move at the speed of their consumers. Keep a track of consumer needs and perspectives, and respond to market trends, to generate profitable business while using the right solutions at the right time.

Gene Therapy Industry Report Scope

The research study focuses on enhancing the basic knowledge of the market professionals about the main product/service, by explicating details like definition, its uses and applications, industry segmentation as well as a global industry outlook. The report further helps in making sound investment decision by listing factors that will contribute to the growth of market worldwide. The study also details about the foreign trade of the product along with the list of major importing and top exporting countries. The research study will also help understand graphical representation and forecasts of key data.

Market Segmentation

Minds Insights provides an analysis of the key trends in each segment of the Gene Therapy-market report, along with forecasts for growth at the region, country and global level from 2021-2027. Our report has categorized the market based on type, application and region.

On the basis of the Type:

  • Somatic Gene Therapy
  • Germline Therapy
  • Others

On the basis of the Application:

  • Oncology
  • Rare Diseases
  • Infectious Disease
  • Others

Important regions covered:

  • North America: USA | Canada
  • Europe: UK | Germany | France |Spain | Italy | Russia | Netherlands | Belgium | Switzerland | Rest of Europe
  • Asia-Pacific: China | Japan | India |South Korea | Australia | Indonesia | Thailand | Philippines | Vietnam | Rest of Asia-Pacific
  • LAMEA: Brazil| Mexico | Argentina | Colombia | Chile | Peru | Rest of LAMEA
  • Middle East: Turkey | Saudi Arabia | United Arab Emirates| South Africa| Israel | Egypt |Nigeria | Rest of Middle East

Competitive Analysis

The report also includes key company profiles in Gene Therapy Industry with their market strategies and SWOT analysis. The report focuses on the industry’s main competitors with information such as business profiles, components and financial information of the past 5 years, and key developments. The competitive landscape of the industry has been examined along with the profiles of the key players:

  • REGENXBIO, Inc.
  • Oxford BioMedica plc
  • Dimension Therapeutics, Inc.
  • Bristol-Myers Squibb Company
  • SANOFI
  • Applied Genetic Technologies Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bluebird Bio, Inc.
  • Novartis AG
  • Taxus Cardium Pharmaceuticals Group, Inc.
  • UniQure N.V.
  • Shire Plc

The report describes prominent players in the Gene Therapy market segment along with their basic profile, company information and recent developments. The report includes crucial information like manufacturing process, raw material requirements and supply-demand side. For investors, and new ventures the report includes information such as costs involved, revenue, market share and size, growth prospects involved.

Major factors covered in this report

  • Market Dynamics: Market Drivers and Restraints
  • Value-Chain: Supply and Demand Analysis
  • Cost and Price Structure Analysis
  • Competitive Analysis
  • Porter’s Five Forces Analysis

What will the report include?

  • Highlights of main global R&D activities and new technological developments
  • Estimation of the actual market size and revenue forecasts for global market
  • Description of the most relevant research and development activities related to Gene Therapy market places
  • Production of Gene Therapy, and review of application for Gene Therapy and assessment of emerging applications
  • Analyses of the global market trends, with data from 2020, estimates for 2021, and forecast through 2027
  • Review of current industry players, including manufacturers of Gene Therapy, technology developments, and future market participants

Some of the key questions addressed in the report were…

  • What were the market size in 2014 and the outlook from 2021 to 2027?
  • How much growth will the industry market experience between 2017 and 2027?
  • What are the important factors, constraints, and opportunities, and how they will affect market?
  • What are the key segments of the Gene Therapy market growth and why?
  • Who are the main participants and strategies they use to compete in the market?

Our reports are comprised of thorough analysis which includes business scientific analysis, data engineering, behavioural analysis experts and data strategy statistics based in 15 markets around the world. We use data and intelligence to help our clients build long-term relationship with their consumer.

Minds Insights is the foundation for data driven insights in various industry verticals using four key capabilities:

  • Qualitative Research
  • Quantitative Research
  • Strategy Building
  • Research Design

1          Introduction

  • Research Scope
  • Research Methodology and Assumptions
  • Market Segmentation
  • Definitions

2          Executive Summary

3          Market Overview

  • Market Segmentation & Scope
  • Value Chain Analysis
  • Supply Chain Analysis
  • Porter’s Five Forces Analysis
  • Regulatory Landscape
  • Macro-Economic Indicators
  • Cost Structure Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Market Evaluation

4          Impact of COVID-19 on the Market

5          Technological Analysis

  • Technology advances
  • Upcoming Technology Landscape

6          Competitive Analysis

  • Market Share Analysis
  • Potential Venture Analysis
  • Key Winning Strategies

7          Pricing Analysis

  • Regional Price Analysis
  • Raw Material Analysis

8          Gene Therapy Market, By Type Overview

  • SOMATIC GENE THERAPY
  • GERMLINE THERAPY
  • OTHER

9          Gene Therapy Market, By Applications Overview

  • ONCOLOGY
  • RARE DISEASES
  • INFECTIOUS DISEASE

10        Regional Overview

  • Overview
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
  • Rest of the World
  • Latin America
  • Middle East and Africa

11        Competitive Landscape (Manufacturers & Suppliers)

INTRODUCTION (Business Overview, Platform, Solutions & Services, Key Insights, Recent Developments, SWOT Analysis)

  • REGENXBIO, INC.
  • OXFORD BIOMEDICA PLC
  • DIMENSION THERAPEUTICS, INC.
  • BRISTOL-MYERS SQUIBB COMPANY
  • SANOFI
  • APPLIED GENETIC TECHNOLOGIES CORPORATION
  • F. HOFFMANN-LA ROCHE LTD.
  • BLUEBIRD BIO, INC.
  • NOVARTIS AG
  • TAXUS CARDIUM PHARMACEUTICALS GROUP, INC.

12        Conclusion & Recommendation

13        Analyst Review

14        Research Methodology

List of Figures

Fig.1    Product Picture of Gene Therapy

Fig.2    Global Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.3    Global Gene Therapy Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)

Fig.4    Global Gene Therapy Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)

Fig.5    COVID-19 Impacts on Gene Therapy Market

Fig.6    COVID-19 Impact on the Players

Fig.7    Business Strategies and Recommendations

Fig.8    Global Gene Therapy Market Share, By Type, 2019 & 2026 (USD Million)

Fig.9    Global SOMATIC GENE THERAPY Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.10  Global GERMLINE THERAPY Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.11  Global OTHER Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.12  Global Gene Therapy Market Share, By Application, 2019 & 2026 (USD Million)

Fig.13  Global ONCOLOGY Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.14  Global RARE DISEASES Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.15  Global INFECTIOUS DISEASE Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.16  Global Gene Therapy Market Share, by Region, 2019 & 2026 (USD Million)

Fig.17  North America Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.18  U.S. Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.19  Canada Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.20  Europe Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.21  Germany Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.22  France Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.23  U.K. Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.24  Italy Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.25  Spain Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.26  Portugal Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.27  Cyprus Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.28  Lithuania Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.29  Greece Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.30  Rest of Europe Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.31  Asia Pacific Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.32  China Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.33  Japan Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.34  India Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.35  South Korea Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.36  Rest of Asia Pacific Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.37  Latin America Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.38  Brazil Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.39  Mexico Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.40  Rest of Latin America Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.41  The Middle-East and Africa Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.42  GCC Countries Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.43  South Africa Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.44  Rest of Middle-East Africa Gene Therapy Market, 2016 – 2026 (USD Million)

Fig.45  Competitor Market Share – Revenue

Fig.46  REGENXBIO, INC. Revenue and Growth Rate

Fig.47  REGENXBIO, INC. Market Share

Fig.48 OXFORD BIOMEDICA PLC Revenue and Growth Rate

Fig.49  OXFORD BIOMEDICA PLC Market Share

Fig.50  DIMENSION THERAPEUTICS, INC. Revenue and Growth Rate

Fig.51  DIMENSION THERAPEUTICS, INC. Market Share

Fig.51  BRISTOL-MYERS SQUIBB COMPANY Revenue and Growth Rate

Fig.52  BRISTOL-MYERS SQUIBB COMPANY Market Share

Fig.53  SANOFI Revenue and Growth Rate

Fig.54  SANOFI Market Share

Fig.55  APPLIED GENETIC TECHNOLOGIES CORPORATION Revenue and Growth Rate

Fig.56  APPLIED GENETIC TECHNOLOGIES CORPORATION Market Share

Fig.57  F. HOFFMANN-LA ROCHE LTD. Revenue and Growth Rate

Fig.58  F. HOFFMANN-LA ROCHE LTD. Market Share

Fig.59  BLUEBIRD BIO, INC. Revenue and Growth Rate

Fig.60  BLUEBIRD BIO, INC. Market Share

Fig.61  NOVARTIS AG Revenue and Growth Rate

Fig.62  NOVARTIS AG Market Share

Fig.63  TAXUS CARDIUM PHARMACEUTICALS GROUP, INC. Revenue and Growth Rate

Fig.64  TAXUS CARDIUM PHARMACEUTICALS GROUP, INC. Market Share

Fig.65  Global Gene Therapy Market – Value Chain Analysis

Fig.66  Technology Roadmap and Timeline

Fig.67  Market Attractiveness Analysis – By Installation

Fig.68  Market Attractiveness Analysis – By Application

Fig.69  Market Attractiveness Analysis – By Region

 

List of Tables

Table 1 Global Gene Therapy Market, 2019 & 2026 (USD Million)

Table 2 Global Gene Therapy Market, By Type, 2016 – 2026 (USD Million)

Table 3 Global Gene Therapy Market, By Installation, 2016 – 2026 (USD Million)

Table 4 Global Gene Therapy Market, By Application, 2016 – 2026 (USD Million)

Table 5 Global Gene Therapy Market, by Region, 2016 – 2026 (USD Million)

Table 6 North America Gene Therapy Market, by Country, 2016 – 2026 (USD Million)

Table 7 North America Gene Therapy Market, By Type, 2016 – 2026 (USD Million)

Table 8 North America Gene Therapy Market, By Installation, 2016 – 2026 (USD Million)

Table 9 North America Gene Therapy Market, By Application, 2016 – 2026 (USD Million)

Table 10 Europe Gene Therapy Market, by Country, 2016 – 2026 (USD Million)

Table 11 Europe Gene Therapy Market, By Type, 2016 – 2026 (USD Million)

Table 12 Europe Gene Therapy Market, By Installation, 2016 – 2026 (USD Million)

Table 13 Europe Gene Therapy Market, By Application, 2016 – 2026 (USD Million)

Table 14 Asia Pacific Gene Therapy Market, by Country, 2016 – 2026 (USD Million)

Table 15 Asia Pacific Gene Therapy Market, By Type, 2016 – 2026 (USD Million)

Table 16 Asia Pacific Gene Therapy Market, By Installation, 2016 – 2026 (USD Million)

Table 17 Asia Pacific Gene Therapy Market, By Application, 2016 – 2026 (USD Million)

Table 18 Latin America Gene Therapy Market, by Country, 2016 – 2026 (USD Million)

Table 19 Latin America Gene Therapy Market, By Type, 2016 – 2026 (USD Million)

Table 20 Latin America Gene Therapy Market, By Installation, 2016 – 2026 (USD Million)

Table 21 Latin America Gene Therapy Market, By Application, 2016 – 2026 (USD Million)

Table 22 The Middle-East and Africa Gene Therapy Market, by Country, 2016 – 2026 (USD Million)

Table 23 The Middle-East and Africa Gene Therapy Market, By Type, 2016 – 2026 (USD Million)

Table 24 The Middle-East and Africa Gene Therapy Market, By Installation, 2016 – 2026 (USD Million)

Table 25 The Middle-East and Africa Gene Therapy Market, By Application, 2016 – 2026 (USD Million)

Table 26 Global Gene Therapy Market - Company Revenue Analysis, 2016 – 2019 (USD Million)

Table 27 Global Gene Therapy Market - Company Revenue Share Analysis, 2016 – 2019 (%)

Table 28 Acquisitions and Mergers

Table 29 Market Drivers – Impact Analysis

Table 30 Market Restraints

Table 31 Market Opportunities